Physician

William M Tang, M.D.

According to 2025 Medicare claims, William Tang, M.D. (NPI: 1972540177) practices ophthalmology in the Cambridge-Newton-Framingham, MA market, with the plurality of this provider's patient population coming from Middlesex, MA. This provider's primary affiliated billing organization is RETINA EYE CARE P.C. (NPI: 1639236714; TIN: 043568119) and primary practice location at 01760-3756.

Tang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,148 traditional Medicare patients, billed 27,266 HCPCS/CPT codes, and received $2,380,600 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,194 prescription claims across 247 beneficiaries totaling $69,079 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 2 records totaling $47. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $930,010 to $2,380,600. Similarly, Part D prescription costs have risen steadily, from $29,182 to $69,079. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.4M2015 Medicare payment: $930,010 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,061,550 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $952,594 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,014,722 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,073,143 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,176,633 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,814,625 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,986,585 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,925,217 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,380,600 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157445,811$930,010
20168345,872$1,061,550
20178816,118$952,594
20189436,310$1,014,722
20191,0277,077$1,073,143
20201,0267,470$1,176,633
20211,1889,249$1,814,625
20221,15410,162$1,986,585
20231,13713,541$1,925,217
20241,14827,266$2,380,600

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$46K$92K2015 Drug cost: $29,182 (USD; Tot_Drug_Cst)2016 Drug cost: $41,420 (USD; Tot_Drug_Cst)2017 Drug cost: $43,217 (USD; Tot_Drug_Cst)2018 Drug cost: $45,724 (USD; Tot_Drug_Cst)2019 Drug cost: $52,034 (USD; Tot_Drug_Cst)2020 Drug cost: $58,957 (USD; Tot_Drug_Cst)2021 Drug cost: $73,623 (USD; Tot_Drug_Cst)2022 Drug cost: $92,139 (USD; Tot_Drug_Cst)2023 Drug cost: $80,487 (USD; Tot_Drug_Cst)2024 Drug cost: $69,079 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015117622$29,182
2016163915$41,420
2017138781$43,217
2018166939$45,724
2019195904$52,034
20202451,146$58,957
20213011,510$73,623
20222541,350$92,139
20232451,186$80,487
20242471,194$69,079

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2531,440$108
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more641654$102
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more589813$72
92134Imaging of retina6461,063$34
92250Photography of the retina711730$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium712,232$13,207
ProlensaBromfenac Sodium341,377$11,895
VyzultaLatanoprostene Bunod23942$8,117
Prednisolone AcetatePrednisolone Acetate1075,456$6,998
LatanoprostLatanoprost31318,001$4,257

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$47EAGLE PHARMACEUTICALS, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for William M. Tang, M.D.?

Tedicare shows public-source Medicare data for William M. Tang, M.D. (NPI 1972540177), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William M. Tang, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to William M. Tang, M.D.?

William M. Tang, M.D. is linked to RETINA EYE CARE P.C. (billing NPI 1639236714) in the available physician profile data.

Does William M. Tang, M.D. have Open Payments data?

William M. Tang, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.